|
Welcome to datamethods
|
|
1
|
12332
|
July 24, 2018
|
|
RMS Cox PH Model
|
|
44
|
3263
|
October 17, 2024
|
|
RMS Discussions
|
|
357
|
82756
|
October 17, 2024
|
|
R vs. Python in academia
|
|
8
|
179
|
October 15, 2024
|
|
Randomized non-comparative trials: an oxymoron?
|
|
16
|
869
|
October 15, 2024
|
|
Estimating totals at group level
|
|
1
|
73
|
October 15, 2024
|
|
RMS Ordinal Logistic Regression
|
|
52
|
15697
|
October 15, 2024
|
|
Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements
|
|
79
|
19212
|
October 14, 2024
|
|
Some thoughts on uniform prior probabilities when estimating P values and confidence intervals
|
|
43
|
2616
|
October 12, 2024
|
|
Randomized trial with variation around pre-specified follow-up times
|
|
5
|
1967
|
October 10, 2024
|
|
Trying variable clustering followed by PC1 scoring
|
|
3
|
235
|
October 7, 2024
|
|
RMS Describing, Resampling, Validating, and Simplifying the Model
|
|
164
|
43845
|
September 29, 2024
|
|
RMS Case Study in Cox Regression
|
|
4
|
15865
|
September 28, 2024
|
|
The End of the "Syndrome" in Critical Care
|
|
71
|
17055
|
September 26, 2024
|
|
Bayesian Regression Modeling Strategies
|
|
94
|
9667
|
September 23, 2024
|
|
Equipoise lost in RCTs - dropout at random assignment
|
|
5
|
199
|
September 23, 2024
|
|
Why not use the inverse logit transformation to get fitted risks (probabilities) in epi?
|
|
16
|
7716
|
September 21, 2024
|
|
Dynamic regression for survival analysis
|
|
0
|
175
|
September 18, 2024
|
|
AUC for different decision thresholds in an ordinal model
|
|
2
|
208
|
September 17, 2024
|
|
Interpreting the coefficient of a log transformed dependent variable
|
|
2
|
301
|
September 11, 2024
|
|
Bayes for Medical Quality Improvement Analysis
|
|
2
|
263
|
September 10, 2024
|
|
Sensitivity analysis
|
|
0
|
232
|
September 10, 2024
|
|
Improving the model recalibration
|
|
3
|
308
|
September 6, 2024
|
|
RMS Semiparametric Ordinal Longitudinal Model
|
|
15
|
11366
|
September 4, 2024
|
|
Percent change in bone mineral density (BMD) as a surrogate endpoint for fractures
|
|
6
|
2816
|
September 3, 2024
|
|
Learning how to conduct and design meaningful clinical trials
|
|
8
|
434
|
September 3, 2024
|
|
How do we count number of variables to compile with the 15:1 EVP rule?
|
|
4
|
368
|
September 3, 2024
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
13
|
626
|
September 2, 2024
|
|
Non-collapsibility of standardized rate
|
|
14
|
476
|
August 31, 2024
|
|
Sample Size in crossover trials
|
|
4
|
374
|
August 29, 2024
|